LUMISENSE Trademark

Trademark Overview


On Tuesday, February 14, 2023, a trademark application was filed for LUMISENSE with the United States Patent and Trademark Office. The USPTO has given the LUMISENSE trademark a serial number of 79367837. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, May 7, 2024. This trademark is owned by Trince, besloten vennootschap. The LUMISENSE trademark is filed in the Pharmaceutical Products category with the following description:

Cells for medical or clinical use; personalized autologous or allogeneic cell-based therapies in the nature of cells for medical use; biological preparations for use in cell cultures for medical applications; pharmaceutical preparations and substances for the treatment of genetic diseases in the nature of single-gene disorders, immunological diseases and cancer; pharmaceutical preparations and substances for applications in tissue engineering and regenerative medicine for cell transplantation, stem cell therapy and gene therapy; reagents for medical use; biological reagents for medical use; diagnostic reagents for medical use; reagents for use in medical genetic testing; stem cells for medical purposes; engineered medicinal cell-based products, cell lines and biomolecules, namely, genetically engineered cells for medical use; medical reagents contained in a cartridge for medical diagnostic use
lumisense

General Information


Serial Number79367837
Word MarkLUMISENSE
Filing DateTuesday, February 14, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, May 7, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 7, 2024

Trademark Statements


Goods and ServicesCells for medical or clinical use; personalized autologous or allogeneic cell-based therapies in the nature of cells for medical use; biological preparations for use in cell cultures for medical applications; pharmaceutical preparations and substances for the treatment of genetic diseases in the nature of single-gene disorders, immunological diseases and cancer; pharmaceutical preparations and substances for applications in tissue engineering and regenerative medicine for cell transplantation, stem cell therapy and gene therapy; reagents for medical use; biological reagents for medical use; diagnostic reagents for medical use; reagents for use in medical genetic testing; stem cells for medical purposes; engineered medicinal cell-based products, cell lines and biomolecules, namely, genetically engineered cells for medical use; medical reagents contained in a cartridge for medical diagnostic use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 21, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTrince, besloten vennootschap
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBE

Party NameTrince, besloten vennootschap
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBE

Trademark Events


Event DateEvent Description
Thursday, April 20, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, April 21, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 25, 2023APPLICATION FILING RECEIPT MAILED
Sunday, June 4, 2023NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, November 14, 2023ASSIGNED TO EXAMINER
Wednesday, November 15, 2023NON-FINAL ACTION WRITTEN
Thursday, November 16, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, November 16, 2023REFUSAL PROCESSED BY MPU
Thursday, November 16, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, December 4, 2023REFUSAL PROCESSED BY IB
Thursday, December 21, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, December 21, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, December 21, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 21, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 21, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, December 21, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 2, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 2, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 2, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 17, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 17, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, April 17, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 7, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, May 8, 2024NOTIFICATION PROCESSED BY IB
Tuesday, May 7, 2024PUBLISHED FOR OPPOSITION
Wednesday, April 3, 2024APPROVED FOR PUB - PRINCIPAL REGISTER